National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Who We Are and What We Do
 Organization
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 About the Director
 Working at NIAID
 Finding People
 Visitor Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

HIV/AIDS Network Clinical Trials Units (CTU) and Clinical Research Sites (CRS)

As of December 1, 2008

NIAID has funded the following Clinical Trials Units (CTU) and their associated Clinical Research Sites (CRS) to implement the clinical research plans of one or more of the six NIAID-funded HIV/AIDS Clinical Trials Networks (see listing to the right).

The HIV/AIDS Clinical Trials Networks and their CTU/CRS will pursue clinical trials to address the highest priorities in HIV/AIDS research, including: (1) vaccine research and development; (2) translational research/drug development; (3) optimization of clinical management, including co-morbidities; (4) microbicides; (5) prevention of mother-to-child transmission of HIV; and (6) prevention of HIV infection.

Clinical Trials Units and Clinical Research Sites Listing (as of December 1, 2008):

back to top

 

NIAID-sponsored HIV/AIDS Clinical Trial Networks

AIDS Clinical Trials Group (ACTG)

HIV Vaccine Trials Network (HVTN)

HIV Prevention Trials Network (HPTN)

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)

Microbicide Trials Network (MTN)

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

All NIAID-sponsored HIV/AIDS Clinical Trials Networks


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
Nov. 3, 2009

Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
Oct. 15, 2009

National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
Sept. 25, 2009

HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
Sept. 24, 2009

Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS


     

    NIAID-sponsored HIV/AIDS Clinical Trial Networks

    AIDS Clinical Trials Group (ACTG)

    HIV Vaccine Trials Network (HVTN)

    HIV Prevention Trials Network (HPTN)

    International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)

    Microbicide Trials Network (MTN)

    International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

    All NIAID-sponsored HIV/AIDS Clinical Trials Networks


    Highlights

    Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
    Feb. 1, 2008

    News Releases

    NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
    Nov. 3, 2009

    Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
    Oct. 15, 2009

    National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
    Sept. 25, 2009

    HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
    Sept. 24, 2009

    Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS